Comparative Pharmacology
Head-to-head clinical analysis: THALITONE versus ZAROXOLYN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: THALITONE versus ZAROXOLYN.
THALITONE vs ZAROXOLYN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Thalidone (chlorthalidone) is a thiazide-like diuretic that inhibits sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, increasing excretion of sodium, chloride, and water. It also reduces peripheral vascular resistance and has a long duration of action (>24 hours).
Inhibits sodium reabsorption in the distal convoluted tubule by blocking the thiazide-sensitive sodium-chloride symporter (NCC).
Oral, 25-100 mg once daily, typically 50 mg daily.
2.5 to 5 mg orally once daily; may increase up to 20 mg daily based on response.
None Documented
None Documented
Terminal elimination half-life is 40-60 hours, allowing once-daily dosing.
Terminal elimination half-life ranges from 6 to 15 hours (mean ~8 hours) in patients with normal renal function. In renal impairment, half-life is prolonged and accumulation may occur.
Primarily renal (approximately 50% unchanged); biliary/fecal elimination minor (<10%).
Primarily renal (approximately 70% as unchanged drug and metabolites) and biliary (approximately 30% as unchanged drug and metabolites into feces).
Category C
Category C
Thiazide-like Diuretic
Thiazide-like Diuretic